South Korea
· Delayed Price · Currency is KRW Nuriplan Statistics
Total Valuation
Nuriplan has a market cap or net worth of KRW 25.47 billion. The enterprise value is 69.91 billion.
| Market Cap | 25.47B |
| Enterprise Value | 69.91B |
Important Dates
The last earnings date was Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nuriplan has 13.08 million shares outstanding. The number of shares has increased by 47.39% in one year.
| Current Share Class | 13.08M |
| Shares Outstanding | 13.08M |
| Shares Change (YoY) | +47.39% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 26.69% |
| Owned by Institutions (%) | n/a |
| Float | 9.58M |
Valuation Ratios
The trailing PE ratio is 7.70.
| PE Ratio | 7.70 |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | 1.72 |
| P/OCF Ratio | 1.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.78, with an EV/FCF ratio of 4.71.
| EV / Earnings | 20.50 |
| EV / Sales | 0.60 |
| EV / EBITDA | 5.78 |
| EV / EBIT | 8.19 |
| EV / FCF | 4.71 |
Financial Position
The company has a current ratio of 0.70, with a Debt / Equity ratio of 1.07.
| Current Ratio | 0.70 |
| Quick Ratio | 0.37 |
| Debt / Equity | 1.07 |
| Debt / EBITDA | 4.16 |
| Debt / FCF | 3.39 |
| Interest Coverage | 2.49 |
Financial Efficiency
Return on equity (ROE) is 9.41% and return on invested capital (ROIC) is 5.34%.
| Return on Equity (ROE) | 9.41% |
| Return on Assets (ROA) | 3.70% |
| Return on Invested Capital (ROIC) | 5.34% |
| Return on Capital Employed (ROCE) | 12.38% |
| Revenue Per Employee | 2.36B |
| Profits Per Employee | 69.59M |
| Employee Count | 49 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 4.89 |
Taxes
In the past 12 months, Nuriplan has paid 627.10 million in taxes.
| Income Tax | 627.10M |
| Effective Tax Rate | 12.83% |
Stock Price Statistics
The stock price has increased by +27.27% in the last 52 weeks. The beta is 0.62, so Nuriplan's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +27.27% |
| 50-Day Moving Average | 1,596.94 |
| 200-Day Moving Average | 1,434.12 |
| Relative Strength Index (RSI) | 81.66 |
| Average Volume (20 Days) | 255,885 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nuriplan had revenue of KRW 115.87 billion and earned 3.41 billion in profits. Earnings per share was 252.85.
| Revenue | 115.87B |
| Gross Profit | 27.89B |
| Operating Income | 8.54B |
| Pretax Income | 4.89B |
| Net Income | 3.41B |
| EBITDA | 12.10B |
| EBIT | 8.54B |
| Earnings Per Share (EPS) | 252.85 |
Balance Sheet
The company has 10.77 billion in cash and 50.28 billion in debt, giving a net cash position of -39.51 billion or -3,021.93 per share.
| Cash & Cash Equivalents | 10.77B |
| Total Debt | 50.28B |
| Net Cash | -39.51B |
| Net Cash Per Share | -3,021.93 |
| Equity (Book Value) | 46.89B |
| Book Value Per Share | 3,210.27 |
| Working Capital | -23.01B |
Cash Flow
In the last 12 months, operating cash flow was 15.68 billion and capital expenditures -841.05 million, giving a free cash flow of 14.84 billion.
| Operating Cash Flow | 15.68B |
| Capital Expenditures | -841.05M |
| Free Cash Flow | 14.84B |
| FCF Per Share | 1,135.14 |
Margins
Gross margin is 24.07%, with operating and profit margins of 7.37% and 2.94%.
| Gross Margin | 24.07% |
| Operating Margin | 7.37% |
| Pretax Margin | 4.22% |
| Profit Margin | 2.94% |
| EBITDA Margin | 10.44% |
| EBIT Margin | 7.37% |
| FCF Margin | 12.81% |
Dividends & Yields
Nuriplan does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.39% |
| Shareholder Yield | n/a |
| Earnings Yield | 13.39% |
| FCF Yield | 58.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nuriplan has an Altman Z-Score of 0.91 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.91 |
| Piotroski F-Score | 6 |